Carl Zeiss Meditec AG (LON:0DHC)

London flag London · Delayed Price · Currency is GBP · Price in EUR
27.22
-1.00 (-3.54%)
At close: Feb 11, 2026
Market Cap2.06B -52.1%
Revenue (ttm)1.94B +7.8%
Net Income123.26M -21.0%
EPS1.41 -19.8%
Shares Outn/a
PE Ratio16.75
Forward PE15.86
Dividend0.50 (1.77%)
Ex-Dividend DateMar 27, 2025
Volume475,689
Average Volume94,382
Open28.32
Previous Close28.22
Day's Range27.12 - 28.44
52-Week Range26.92 - 71.60
Beta1.44
RSI24.97
Earnings DateFeb 12, 2026

About Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for retina examination; functional glaucoma diagnostic devices (perimeters); surgical ophthalmology products comprising surgical microscopes, biometers, and p... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 1846
Employees 5,784
Stock Exchange London Stock Exchange
Ticker Symbol 0DHC
Full Company Profile

Financial Performance

In fiscal year 2025, Carl Zeiss Meditec AG's revenue was 2.23 billion, an increase of 7.82% compared to the previous year's 2.07 billion. Earnings were 141.21 million, a decrease of -20.99%.

Financial numbers in EUR Financial Statements